Given that PD-1 and CTLA-4 participate in different processes of T cell recognition and cytotoxic T cell reinvigoration, combinations of antibodies against PD-1 and CTLA-4 are of great potential to induce tumor regression synergistically. Here, CTLA4 is linked to neoplasm.